A lot of European companies are quietly asking the same question in 2026: was the Delaware flip worth it? Founder demand was visible before the regulation moved — see the industry-led signature campaign at eu-inc.org. For many of them, the honest answer is probably not, given what's coming. EU INC — the proposed 28th EU corporate regime — converges on most of the problems the Delaware flip was supposed to solve: single-market recognition, EU-wide option plans, clean cross-border investor mechanics.
This article isn't about whether to flip in the first place. It's for companies who already flipped and are now wondering if they jumped too soon.
New to EU INC? Here's a quick primer before you read on:
The short answer
You can't redomicile a Delaware C-Corp directly into an EU INC — Delaware isn't a European jurisdiction, and there's no direct conversion mechanism. Instead, you create a new EU INC and migrate the business into it. Three structures are commonly used:
- Cross-border merger. The EU INC absorbs the Delaware entity. Investors and option holders roll into the EU INC at the exchange ratio.
- Asset transfer. A newly incorporated EU INC buys the Delaware company's business, IP and contracts. The Delaware shell is then wound down.
- Reverse F-reorganisation. Delaware becomes a subsidiary of the EU INC (share-for-share), after which the Delaware entity is often dissolved.
All three are standard M&A tools. What's new is that — for the first time — EU INC gives European companies a clean, pan-European parent destination rather than forcing them into one of the 27 national corporate forms.
When reversing the flip makes sense
Be honest about whether any of these describe you:
- Your operations, customers and team are overwhelmingly European and likely to stay that way.
- You're losing out on EU grants or public funding (EIC, Horizon, national innovation grants) because of your US structure.
- Your ESOP is painful to administer across European employees — ISOs/NSOs that don't map cleanly to local tax regimes.
- You have no realistic line of sight to a US IPO.
- Your lead investors are European, or US funds comfortable investing into EU entities.
- Your cap table is simple enough that a migration is tractable.
If three or more of these hit, EU INC is worth serious consideration the day it goes live.
When staying in Delaware is still right
Don't undo the flip if:
- You've relocated the founding team to the US and that's not reversing.
- Your customers and revenue are overwhelmingly US-denominated.
- Your exit strategy is explicitly a NASDAQ/NYSE IPO or US strategic acquirer.
- You have a large US-located workforce with substantial ISOs already granted.
- Your lead investor has case-specific contractual constraints on non-US holding structures.
Delaware (today) vs EU INC (where you could go)
You already chose Delaware. The question isn't which is better in the abstract — it's whether the delta is worth the migration cost. Here's the delta:
| Criterion | Delaware C-Corp (today) | EU INC (where you could move) |
|---|---|---|
| Primary market | United States | European single market |
| Recognised across EU | ✗ needs EU sub | ✓ |
| EU grants & soft funding | Often ineligible | ✓ |
| Personal tax residence | Often pushes companies to US | Founders stay EU |
| Option plan for EU employees | Medium (409A, ISOs/NSOs, per-country tax) | Low (EU-wide ESOP) |
| IP handling | Typically transferred to US parent | Stays in EU entity |
| EU acquirer exits | Friction (US parent structure) | Clean |
| US IPO path | ✓ Proven | Possible via flip-up later |
| Annual admin cost | Medium (US filings, Delaware fees) | Low, digital |
The real costs of moving back
A migration isn't free, and the decision stops being theoretical as soon as you price it:
- Legal fees. Cross-border mergers and reverse F-reorgs typically run €70K–€230K in legal alone, depending on cap-table complexity and IP value.
- Exit tax on IP. If core IP was transferred to the Delaware parent at the time of the original flip, moving it back may trigger US gain recognition. Transfer-pricing analysis needed.
- Cap table consent. Existing investors need to approve. Check your SHA / stockholder agreements — some contain US-structure covenants or require supermajority for jurisdiction changes.
- Tax year timing. Migrations closing late in a fiscal year can create dual-jurisdiction filing complexity for 12+ months.
- Option plan reset. 409A valuations don't carry over to EU INC. You'll need fresh valuations and possibly regranted options under the EU-wide plan.
- Grant eligibility waiting periods. Some EU funding programs require N years of EU residence before the entity qualifies.
Realistic timeline
- EU INC availability: see our regulation timeline.
- Investor consent + board approval: 1–2 months.
- Cross-border merger legal process: 6–12 months (faster for asset transfers).
- Tax clearances: parallel, 3–6 months.
- Total: 9–18 months from decision to completion.
Start the conversation with counsel roughly six months before EU INC go-live if you want to move quickly once it opens.
When to start thinking about it
If you're planning a priced round in late 2026 or 2027, raise it with your lawyers now. New investors will increasingly ask "why Delaware?" for European-operating companies once EU INC is live — and the answer "because I flipped two years ago" won't satisfy sophisticated funds if the underlying economics have shifted.
What to do now
If you're Delaware-incorporated today and this resonates: join the INC48 waitlist for regulation updates, migration timelines and practical how-to guides as EU INC matures.